FEBRUARY 14, 2012

IPF 2009 - What is new with PSA? - Session Highlights

E-mail Print

IZMIR, TURKEY (UroToday.com) - PSA is a biomarker for future prostate cancer risk.




Your session will expire in 8 hours requiring you to log in each day to view content.
Share |